Rolf‐Detlef Treede

Follow

Generating author description...

Common Coauthors
Commonly Cited References
Action Title Year Authors # of times referenced
+ Efficacy and tolerability of a spray with Salvia officinalis in the treatment of acute pharyngitis - a randomised, double-blind, placebo-controlled study with adaptive design and interim analysis. 2006 Michael Hubbert
Hans‐Hinrich Sievers
R Lehnfeld
W. Kehrl
1
+ Evaluation of Biomarkers and Surrogate Endpoints in Chronic Disease 2010 Christine Micheel
John R. Ball
1
+ The run-in period in clinical trials 1990 Erica Brittain
Janet Wittes
1
+ Explanatory and Pragmatic Attitudes in Therapeutical Trials 2009 Daniel Schwartz
J Lellouch
1
+ Quantitative Analysis of Cerebral Asymmetries 1986 David M. Bear
1
+ An examination of the efficiency of the sequential parallel design in psychiatric clinical trials 2007 Roy Tamura
Xiaohong Huang
1
+ Innovative Approaches for Designing and Analyzing Adaptive Dose-Ranging Trials 2007 Björn Bornkamp
Frank Bretz
Alex Dmitrienko
Greg Enas
Brenda Gaydos
Chyi‐Hung Hsu
Franz König
Michael Krams
Qing Liu
Beat Neuenschwander
1
+ An Introduction to the Bootstrap 1994 Bradley Efron
Robert Tibshirani
1
+ Implementation of a Bayesian adaptive design in a proof of concept study 2006 Michael K. Smith
Ieuan Jones
Mark Morris
Andrew P. Grieve
Keith Tan
1
+ PDF Chat The Prevention and Treatment of Missing Data in Clinical Trials 2012 Roderick J. A. Little
Ralph B. D’Agostino
Michael L. Cohen
Kay Dickersin
Scott S. Emerson
John T. Farrar
Constantine Frangakis
Joseph W. Hogan
Geert Molenberghs
Susan A. Murphy
1
+ Adaptive Designs in Clinical Drug Development—An Executive Summary of the PhRMA Working Group 2006 Paul Gallo
Christy Chuang‐Stein
Vladimir Dragalin
Brenda Gaydos
Michael Krams
José Cirı́aco Pinheiro
1
+ N-of-1 Trials in the Medical Literature 2011 Nicole B. Gabler
Naihua Duan
Sunita Vohra
Richard L. Kravitz
1
+ Good Practices for Adaptive Clinical Trials in Pharmaceutical Product Development 2009 Brenda Gaydos
Keaven M. Anderson
Donald A. Berry
Nancy Burnham
Christy Chuang‐Stein
Jennifer Dudinak
Parvin Fardipour
Paul Gallo
Sam Givens
Roger Lewis
1
+ Anatomical Signatures of Dyslexia in Children: Unique Information from Manual and Voxel Based Morphometry Brain Measures 2005 Mark A. Eckert
Christiana M. Leonard
Marko Wilke
Mathew Eckert
Todd L. Richards
Anne Richards
Virginia W. Berninger
1
+ PDF Chat Adaptive design methods in clinical trials – a review 2008 Shein‐Chung Chow
Mark Chang
1
+ Enrichment of Clinical Study Populations 2010 Robert Temple
1
+ Diagnostics for confounding in PK/PD models for oxcarbazepine 2006 Jerry Nedelman
Donald B. Rubin
Lewis B. Sheiner
1
+ Mid‐course sample size modification in clinical trials based on the observed treatment effect 2003 Christopher Jennison
Bruce W. Turnbull
1
+ Cross-Over Trials in Clinical Research 1994 Stephen Senn
1
+ Analysis of Nonrandomly Censored Ordered Categorical Longitudinal Data from Analgesic Trials 1997 Lewis B. Sheiner
Stuart L. Beal
Adrian Dunne
1
+ A new approach to the analysis of analgesic drug trials, illustrated with bromfenac data 1994 L B Sheiner
1
+ Sample size re‐estimation in clinical trials 2009 Michael A. Proschan
1
+ PDF Chat Addressing Missing Data in Clinical Trials 2011 Thomas R. Fleming
1
+ Optimal designs for estimating the most successful dose 2006 Sarah Zohar
John O’Quigley
1
+ Bayesian clinical trials 2006 Donald A. Berry
1
+ Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing 1995 Yoav Benjamini
Yosef Hochberg
1
+ PDF Chat Dose Escalation Methods in Phase I Cancer Clinical Trials 2009 Christophe Le Tourneau
J. Jack Lee
Lillian L. Siu
1
+ Bridging the efficacy–effectiveness gap: a regulator's perspective on addressing variability of drug response 2011 Hans‐Georg Eichler
Éric Abadie
Alasdair Breckenridge
Bruno Flamion
Lars L. Gustafsson
Hubert G. M. Leufkens
Malcolm Rowland
Christian K. Schneider
Brigitte Bloechl‐Daum
1
+ Increasing trial efficiency by early reallocation of placebo nonresponders in sequential parallel comparison designs: Application to antidepressant trials 2012 Ruud Boessen
Mirjam J. Knol
Rolf H. H. Groenwold
Diederick E. Grobbee
Kit CB Roes
1
+ Threats to the Validity of Clinical Trials Employing Enrichment Strategies for Sample Selection 1998 P Leber
Charles S. Davis
1
+ Statistical Issues in Drug Development 2021 Stephen Senn
1
+ PDF Chat Adaptive dose finding based on <i>t</i>‐statistic for dose–response trials 2008 Anastasia Ivanova
James A. Bolognese
Inna Perevozskaya
1
+ PDF Chat The design and conduct of clinical trials to limit missing data 2012 Roderick J. A. Little
Matthew L. Cohen
Kay Dickersin
Scott S. Emerson
John T. Farrar
James D. Neaton
Weichung Joe Shih
Jay P. Siegel
Hal S. Stern
1
+ Cerebral Asymmetry and the Effects of Sex and Handedness on Brain Structure: A Voxel-Based Morphometric Analysis of 465 Normal Adult Human Brains 2001 Catriona D. Good
Ingrid S. Johnsrude
John Ashburner
Richard N. Henson
Karl Friston
R. S. J. Frackowiak
1
+ A comprehensive algorithm for determining whether a run‐in strategy will be a cost‐effective design modification in a randomized clinical trial 1993 Kenneth B. Schechtman
Mae E. Gordon
1
+ Improvement of phase III psychotropic drug trials by intensive phase II work. 1991 D F Klein
1
+ Adaptive Designs: Terminology and Classification 2006 Vladimir Dragalin
1
+ PDF Chat When power analyses based on pilot data are biased: Inaccurate effect size estimators and follow-up bias 2017 Casper J. Albers
Daniël Lakens
1